A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma
Clinical trial NCT07099430 · RECRUITING
Trial details
- NCT number
- NCT07099430
- Sponsor
- Nanjing Leads Biolabs Co.,Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-05
- Primary completion
- 2027-10-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.